The Anti-TNFRSF10B (TIGATUZUMAB) Biosimilar Monoclonal Antibody (HDBS0032) is a cutting-edge product developed for researchers studying TNFRSF10B, a cell surface receptor known to play a role in apoptosis and immune regulation. This biosimilar monoclonal antibody, produced using advanced technology, is highly specific and sensitive for detecting TNFRSF10B in human samples. Validated for use in various immunoassays, including ELISA and immunohistochemistry, this antibody enables precise detection and analysis of TNFRSF10B expression in different cell types.
TNFRSF10B, also known as TIGATUZUMAB, is a key player in regulating cell death pathways and immune responses, making it a promising target for cancer therapy and immunotherapy research. Its involvement in promoting apoptosis and inhibiting tumor growth highlights its potential as a therapeutic target for developing novel cancer treatments. Researchers studying TNFRSF10B's biological functions and signaling pathways will find this biosimilar monoclonal antibody indispensable for their experiments and investigations.
Product Name:
Tigatuzumab (Anti-TNFRSF10B) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0032
Target:
TNFRSF10B
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
GEN-1029, HexaBody-DR5/DR5, Hx-DR5-01/05
Description:
Anti-TNFRSF10B (tigatuzumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
